ADMA BIOLOGICS, INC. Property, Plant and Equipment, Gross
ADMA BIOLOGICS, INC. (ADMA) had Property, Plant and Equipment, Gross of $108.38 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $108.38M.
- 2026-03-31: Property, Plant and Equipment, Gross $105.00M.
- 2025-12-31: Property, Plant and Equipment, Gross $103.41M.
- 2025-06-30: Property, Plant and Equipment, Gross $95.02M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $108.38M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $105.00M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $103.41M 10-Q · filed 2026-08-05 | |
| 2025-06-30 | $95.02M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $93.21M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $88.26M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $86.14M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $84.87M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $83.96M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $80.57M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $79.93M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $79.51M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $78.66M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $77.74M 10-K · filed 2024-02-28 | $77.74M 10-K · filed 2023-03-23 |
| 2022-09-30 | $74.84M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $71.18M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $67.90M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $64.21M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $60.59M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $57.44M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $54.08M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $50.46M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $47.51M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $44.41M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $41.39M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $37.47M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $35.98M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $34.12M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $33.77M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $33.54M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $33.24M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $32.67M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $32.42M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $31.75M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $30.57M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $28.99M 10-Q · filed 2017-08-11 | |
| 2016-12-31 | $4.22M 10-K · filed 2018-03-29 | |
| 2015-12-31 | $4.15M 10-K · filed 2017-02-24 | |
| 2014-12-31 | $4.12M 10-K · filed 2016-03-23 | |
| 2013-12-31 | $1.80M 10-K · filed 2015-03-09 | |
| 2012-12-31 | $1.60M 10-K · filed 2014-03-28 | |
| 2011-12-31 | $1.55M 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |